Skip to main contentSkip to navigation
Print subscriptions
Sign in
Search jobs
Search
The Guardian - Back to homeThe Guardian

Johnson & Johnson

May 2024

  • johnson and johnson sign on a lawn

    Johnson & Johnson proposes $6.5bn settlement of talc cancer lawsuits

    Deal would resolve tens of thousands of lawsuits alleging company’s baby powder causes ovarian cancer

September 2023

  • The Johnson & Johnson logo

    Fair Access
    South Africa launches ‘unprecedented’ investigation of Johnson & Johnson over TB drug prices

    Competition watchdog probes claims of profiteering by US drugmaker in country where tuberculosis is biggest killer

August 2023

  • Johnson & Johnson’s Sirturo, the branded version of bedaquiline.

    Fair Access
    Cost of tuberculosis treatment halved in deal to permit generic versions

    Johnson & Johnson’s year-long deal on life-saving drug bedaquiline is seen as critical move in campaign against disease

July 2023

  • FILE PHOTO: A bottle of Johnson's Baby Powder is seen in a photo illustration taken in New York<br>FILE PHOTO: A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016. REUTERS/Mike Segar/Illustration/File Photo

    Johnson & Johnson must pay $18.8m to cancer patient in baby powder lawsuit

  • Protests at Johnson &amp; Johnson in Zug, Switzerland, in 2019, demanding an end to its monopoly on the tuberculosis drug bedaquiline.

    Fair Access
    Cheaper TB drugs for millions after global deal on patent rights agreed

April 2023

  • Johnson &amp; Johnson To Split Into Two Publicly Traded Companies<br>SAN ANSELMO, CALIFORNIA - NOVEMBER 12: In this photo illustration a bottle of Johnson &amp; Johnson baby powder is displayed on a table on November 12, 2021 in San Anselmo, California. Johnson &amp; Johnson announced plans to split its pharmaceutical and medical devices divisions and consumer products into two publicly traded companies. The company hopes to complete the transaction within two years. (Photo Illustration by Justin Sullivan/Getty Images)

    Johnson & Johnson agrees to pay $8.9bn over alleged cancer-causing talc claims

    The conglomerate was prevented from offloading its liability to a subsidiary that immediately declared bankruptcy

September 2022

  • Pelvic mesh

    Johnson & Johnson reaches $300m settlement over pelvic mesh implants

    Settlement of two Australian class actions is largest in country’s history and subject to federal court approval

August 2022

  • Johnson's baby powder on a shelf

    Johnson & Johnson to stop making talc-based baby powder globally

    Company has faced lawsuits about its talc products but insists they are safe
Explore more on these topics
  翻译：